Annual long term liabilities:
$81.90B-$7.51B(-8.40%)Summary
- As of today (May 29, 2025), PFE annual total long term liabilities is $81.90 billion, with the most recent change of -$7.51 billion (-8.40%) on December 31, 2024.
- During the last 3 years, PFE annual long term liabilities has risen by +$20.56 billion (+33.52%).
- PFE annual long term liabilities is now -8.40% below its all-time high of $89.42 billion, reached on December 31, 2023.
Performance
PFE Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$80.94B-$965.00M(-1.18%)Summary
- As of today (May 29, 2025), PFE quarterly total long term liabilities is $80.94 billion, with the most recent change of -$965.00 million (-1.18%) on March 29, 2025.
- Over the past year, PFE quarterly long term liabilities has dropped by -$7.10 billion (-8.07%).
- PFE quarterly long term liabilities is now -9.48% below its all-time high of $89.42 billion, reached on December 31, 2023.
Performance
PFE quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
PFE Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -8.4% | -8.1% |
| 3 y3 years | +33.5% | +30.8% |
| 5 y5 years | +22.5% | +20.6% |
PFE Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -8.4% | +38.5% | -9.5% | +40.0% |
| 5 y | 5-year | -8.4% | +38.5% | -9.5% | +40.0% |
| alltime | all time | -8.4% | >+9999.0% | -9.5% | >+9999.0% |
PFE Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $80.94B(-1.2%) |
| Dec 2024 | $81.90B(-8.4%) | $81.90B(-2.2%) |
| Sep 2024 | - | $83.71B(-0.8%) |
| Jun 2024 | - | $84.40B(-4.1%) |
| Mar 2024 | - | $88.04B(-1.5%) |
| Dec 2023 | $89.42B(+51.2%) | $89.42B(+3.2%) |
| Sep 2023 | - | $86.68B(+0.5%) |
| Jun 2023 | - | $86.23B(+49.1%) |
| Mar 2023 | - | $57.82B(-2.3%) |
| Dec 2022 | $59.15B(-3.6%) | $59.15B(+1.7%) |
| Sep 2022 | - | $58.15B(-3.8%) |
| Jun 2022 | - | $60.41B(-2.4%) |
| Mar 2022 | - | $61.89B(+0.9%) |
| Dec 2021 | $61.34B(-5.4%) | $61.34B(-0.1%) |
| Sep 2021 | - | $61.42B(-3.9%) |
| Jun 2021 | - | $63.94B(+1.0%) |
| Mar 2021 | - | $63.30B(-2.4%) |
| Dec 2020 | $64.84B(-3.0%) | $64.84B(-18.3%) |
| Sep 2020 | - | $79.33B(-1.6%) |
| Jun 2020 | - | $80.65B(+20.2%) |
| Mar 2020 | - | $67.11B(+0.4%) |
| Dec 2019 | $66.84B(+4.8%) | $66.84B(-1.8%) |
| Sep 2019 | - | $68.08B(+6.0%) |
| Jun 2019 | - | $64.25B(-3.9%) |
| Mar 2019 | - | $66.84B(+4.8%) |
| Dec 2018 | $63.81B(-8.5%) | $63.81B(-5.0%) |
| Sep 2018 | - | $67.16B(+7.1%) |
| Jun 2018 | - | $62.70B(-6.0%) |
| Mar 2018 | - | $66.71B(-4.3%) |
| Dec 2017 | $69.71B(-13.6%) | $69.71B(-15.8%) |
| Sep 2017 | - | $82.82B(+0.2%) |
| Jun 2017 | - | $82.68B(-2.9%) |
| Mar 2017 | - | $85.17B(+5.6%) |
| Dec 2016 | $80.66B(+10.5%) | $80.66B(+0.7%) |
| Sep 2016 | - | $80.07B(+6.1%) |
| Jun 2016 | - | $75.49B(+6.6%) |
| Mar 2016 | - | $70.85B(-2.9%) |
| Dec 2015 | $72.98B(-1.8%) | $72.98B(-3.8%) |
| Sep 2015 | - | $75.90B(+9.1%) |
| Jun 2015 | - | $69.56B(-4.5%) |
| Mar 2015 | - | $72.83B(-2.1%) |
| Dec 2014 | $74.36B(+3.1%) | $74.36B(+1.7%) |
| Sep 2014 | - | $73.14B(-0.8%) |
| Jun 2014 | - | $73.72B(+6.9%) |
| Mar 2014 | - | $68.95B(-4.4%) |
| Dec 2013 | $72.11B(-3.8%) | $72.11B(-6.1%) |
| Sep 2013 | - | $76.79B(-0.1%) |
| Jun 2013 | - | $76.91B(-0.2%) |
| Mar 2013 | - | $77.03B(+2.8%) |
| Dec 2012 | $74.93B(-2.0%) | $74.93B(+5.0%) |
| Sep 2012 | - | $71.36B(-1.0%) |
| Jun 2012 | - | $72.08B(-3.8%) |
| Mar 2012 | - | $74.91B(-2.0%) |
| Dec 2011 | $76.47B(-2.1%) | $76.47B(-1.6%) |
| Sep 2011 | - | $77.75B(+1.7%) |
| Jun 2011 | - | $76.47B(+1.6%) |
| Mar 2011 | - | $75.25B(-3.7%) |
| Dec 2010 | $78.14B(-8.4%) | $78.14B(-1.3%) |
| Sep 2010 | - | $79.17B(-0.4%) |
| Jun 2010 | - | $79.51B(+0.5%) |
| Mar 2010 | - | $79.11B(-7.2%) |
| Dec 2009 | $85.28B(+223.0%) | $85.28B(+67.0%) |
| Sep 2009 | - | $51.05B(+2.1%) |
| Jun 2009 | - | $49.99B(+27.7%) |
| Mar 2009 | - | $39.15B(+48.3%) |
| Dec 2008 | $26.40B(-6.7%) | $26.40B(+0.5%) |
| Sep 2008 | - | $26.25B(-1.3%) |
| Jun 2008 | - | $26.60B(-9.2%) |
| Mar 2008 | - | $29.31B(+3.5%) |
| Dec 2007 | $28.31B(+28.6%) | $28.31B(+0.8%) |
| Sep 2007 | - | $28.09B(+3.4%) |
| Jun 2007 | - | $27.17B(+10.0%) |
| Mar 2007 | - | $24.69B(+12.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2006 | $22.02B(-3.4%) | $22.02B(+3.9%) |
| Sep 2006 | - | $21.18B(-7.9%) |
| Jun 2006 | - | $23.01B(-2.8%) |
| Mar 2006 | - | $23.68B(+3.9%) |
| Dec 2005 | $22.79B(-19.6%) | $22.79B(-1.5%) |
| Sep 2005 | - | $23.14B(-5.3%) |
| Jun 2005 | - | $24.43B(-7.6%) |
| Mar 2005 | - | $26.45B(-6.7%) |
| Dec 2004 | $28.34B(+3.1%) | $28.34B(-0.9%) |
| Sep 2004 | - | $28.61B(+1.8%) |
| Jun 2004 | - | $28.10B(-1.8%) |
| Mar 2004 | - | $28.60B(+4.1%) |
| Dec 2003 | $27.49B(+250.1%) | $27.49B(-8.0%) |
| Sep 2003 | - | $29.87B(-6.1%) |
| Jun 2003 | - | $31.82B(+241.0%) |
| Mar 2003 | - | $9.33B(+18.9%) |
| Dec 2002 | $7.85B(+10.1%) | $7.85B(+4.4%) |
| Sep 2002 | - | $7.52B(+1.4%) |
| Jun 2002 | - | $7.42B(+7.3%) |
| Mar 2002 | - | $6.91B(-3.1%) |
| Dec 2001 | $7.13B(+30.8%) | $7.13B(+3.8%) |
| Sep 2001 | - | $6.87B(-3.8%) |
| Jun 2001 | - | $7.14B(+9.5%) |
| Mar 2001 | - | $6.52B(+19.6%) |
| Dec 2000 | $5.45B(-1.3%) | $5.45B(+9.7%) |
| Sep 2000 | - | $4.97B(+2.5%) |
| Jun 2000 | - | $4.85B(+89.6%) |
| Mar 2000 | - | $2.56B(-53.7%) |
| Dec 1999 | $5.53B(+140.3%) | $5.53B(+134.1%) |
| Sep 1999 | - | $2.36B(+8.4%) |
| Jun 1999 | - | $2.18B(-2.2%) |
| Mar 1999 | - | $2.23B(-3.1%) |
| Dec 1998 | $2.30B(+11.4%) | $2.30B(+1.2%) |
| Sep 1998 | - | $2.27B(+10.1%) |
| Jun 1998 | - | $2.06B(-1.0%) |
| Mar 1998 | - | $2.08B(+1.0%) |
| Dec 1997 | $2.06B(+2.0%) | $2.06B(-2.6%) |
| Sep 1997 | - | $2.12B(+1.1%) |
| Jun 1997 | - | $2.10B(+0.7%) |
| Mar 1997 | - | $2.08B(+2.9%) |
| Dec 1996 | $2.02B(+1.7%) | $2.02B(+12.5%) |
| Sep 1996 | - | $1.80B(+3.5%) |
| Jun 1996 | - | $1.74B(-1.0%) |
| Mar 1996 | - | $1.76B(-11.7%) |
| Dec 1995 | $1.99B(+4.1%) | $1.99B(+17.4%) |
| Sep 1995 | - | $1.69B(-13.9%) |
| Jun 1995 | - | $1.97B(-1.6%) |
| Mar 1995 | - | $2.00B(+4.7%) |
| Dec 1994 | $1.91B(-3.7%) | $1.91B(-7.8%) |
| Sep 1994 | - | $2.07B(+2.1%) |
| Jun 1994 | - | $2.03B(+0.7%) |
| Mar 1994 | - | $2.02B(+1.7%) |
| Dec 1993 | $1.98B(+22.4%) | $1.98B(+5.8%) |
| Sep 1993 | - | $1.87B(+11.5%) |
| Jun 1993 | - | $1.68B(+3.7%) |
| Mar 1993 | - | $1.62B(+0.1%) |
| Dec 1992 | $1.62B(+40.4%) | $1.62B(+15.5%) |
| Sep 1992 | - | $1.40B(+5.4%) |
| Jun 1992 | - | $1.33B(+0.5%) |
| Mar 1992 | - | $1.32B(+14.8%) |
| Dec 1991 | $1.15B(+41.6%) | $1.15B(+70.1%) |
| Sep 1991 | - | $678.20M(-3.7%) |
| Jun 1991 | - | $704.30M(-9.6%) |
| Mar 1991 | - | $779.40M(-4.3%) |
| Dec 1990 | $814.40M(-4.6%) | $814.40M(+0.4%) |
| Sep 1990 | - | $811.50M(-0.5%) |
| Jun 1990 | - | $815.70M(-2.5%) |
| Mar 1990 | - | $837.00M(-1.9%) |
| Dec 1989 | $853.30M(-14.0%) | $853.30M(-14.0%) |
| Dec 1988 | $992.20M(-8.4%) | $992.20M(-8.4%) |
| Dec 1987 | $1.08B(+87.5%) | $1.08B(+87.5%) |
| Dec 1986 | $577.80M(+0.3%) | $577.80M(+0.3%) |
| Dec 1985 | $575.90M(+20.2%) | $575.90M(+20.2%) |
| Dec 1984 | $479.00M | $479.00M |
FAQ
- What is Pfizer annual total long term liabilities?
- What is the all time high annual long term liabilities for Pfizer?
- What is Pfizer annual long term liabilities year-on-year change?
- What is Pfizer quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Pfizer?
- What is Pfizer quarterly long term liabilities year-on-year change?
What is Pfizer annual total long term liabilities?
The current annual long term liabilities of PFE is $81.90B
What is the all time high annual long term liabilities for Pfizer?
Pfizer all-time high annual total long term liabilities is $89.42B
What is Pfizer annual long term liabilities year-on-year change?
Over the past year, PFE annual total long term liabilities has changed by -$7.51B (-8.40%)
What is Pfizer quarterly total long term liabilities?
The current quarterly long term liabilities of PFE is $80.94B
What is the all time high quarterly long term liabilities for Pfizer?
Pfizer all-time high quarterly total long term liabilities is $89.42B
What is Pfizer quarterly long term liabilities year-on-year change?
Over the past year, PFE quarterly total long term liabilities has changed by -$7.10B (-8.07%)